Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase synthesis of endothelin receptor antagonists.

Udo E W Lange1, Wilfried M Braje, Willi Amberg

  • 1BASF AG, D-67056 Ludwigshafen, Germany. udo.lange@abbott.com

Bioorganic & Medicinal Chemistry Letters
|May 6, 2003
PubMed
Summary

A novel solid-phase synthesis method for endothelin (ET) receptor antagonists was developed. This automated approach yields potent and selective ET(A) antagonists efficiently.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transmetallation by Halogen-Cyanide Metathesis in Water: Application to Cyanide Ion-Free Palladium Catalyzed Cyanation.

ACS catalysis·2026
Same author

Sulfoximine and Triazine-Acid Adduct Behavior in Aqueous HPMC: A Fast and Convenient <i>N</i>‑Functionalization of Sulfoximines.

Organic process research & development·2026
Same author

Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project.

ChemSusChem·2025
Same author

Leveraging Data Science to Elucidate Ligand Features for Pd-Catalyzed Enantioretentive <i>N</i>-Arylations of Cyclic α-Substituted Amines in Aqueous Media.

Journal of the American Chemical Society·2025
Same author

Experimental Evidence for Zerovalent Pd(NHC) as a Competent Catalyst in C-N Cross-Coupling (NHC = DiMeIHept<sup>Cl</sup>).

Journal of the American Chemical Society·2024
Same author

Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates.

Heliyon·2024

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Drug Discovery

Background:

  • Endothelin (ET) receptors play crucial roles in cardiovascular and other physiological processes.
  • Development of selective ET receptor antagonists is important for therapeutic applications.
  • Existing synthesis methods may not be amenable to automation or efficient scale-up.

Purpose of the Study:

  • To present a new, automatable solid-phase synthesis strategy for ET receptor antagonists.
  • To explore the synthesis of diverse ET receptor antagonists using this novel method.
  • To evaluate the potency and selectivity of the synthesized compounds.

Main Methods:

  • Solid-phase synthesis utilizing a support-bound 2-hydroxybutyric acid derivative.
  • Ether formation using 4-halo-2-methylsulfonylpyrimidines.

Related Experiment Videos

  • Suzuki coupling with various aryl boronic acids to introduce diverse substituents.

    • Main Results:

    • Successful synthesis of ET receptor antagonists via a solid-phase approach.
    • Good yields and high purity of the synthesized antagonists were achieved.
    • Identification of highly potent antagonists with excellent selectivity for the ET(A) receptor.

    Conclusions:

    • The developed solid-phase synthesis is suitable for automation and efficient production of ET receptor antagonists.
    • This method provides access to potent and selective ET(A) antagonists.
    • The findings contribute to the advancement of drug discovery for conditions involving ET receptor pathways.